Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Experimental Cell Research

• Publication date

  2004-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YEXCR.2003.10.016PMID 14729467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of osteoclast protease expression by RANKL.

  2003cited by this paper
• Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities

  2003cited by this paper
• Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.

  2002cited by this paper
• Osteoprotegerin differentially regulates protease expression in osteoclast cultures.

  2002cited by this paper
• Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin

  2002cited by this paper
• Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.

  2002cited by this paper
• U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells*

  2002cited by this paper
• Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator*

  2002cited by this paper
• The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.

  2002cited by this paper
• Osteoclast differentiation factor modulates cell cycle machinery and causes a delay in s phase progression in RAW264 cells.

  2001cited by this paper
• Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).

  2000cited by this paper
• RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

  2000cited by this paper
• gp130 Cytokine family and bone cells.

  2000cited by this paper
• Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)*

  2000cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone

  1999cited by this paper
• The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts

  1999cited by this paper
• Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

  1999cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

  1999cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

  1998cited by this paper
• Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

  1998cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998cited by this paper
• Cytokines, growth factors and osteoclasts.

  1998cited by this paper
• Cysteine Proteinases and Matrix Metalloproteinases Play Distinct Roles in the Subosteoclastic Resorption Zone

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

  1998cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

  1997cited by this paper
• Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

  1997cited by this paper
• Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency

  1996cited by this paper
• Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts

  1996cited by this paper
• Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*)

  1996cited by this paper
• Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.

  1994cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper

• The mechanism underlying the remodeling effect of lactoferrin on midpalatal sutures during maxillary expansion and relapse in rats.

  2023cites this paper
• Elevated Serum Osteoprotegerin is Associated with Reduced Risks of Albuminuria and CKD Progression in Patients with Type 2 Diabetes

  2022cites this paper
• Mechanisms of sphingosine-1-phosphate (S1P) signaling on excessive stress-induced root resorption during orthodontic molar intrusion

  2021cites this paper
• LncRNA NORAD promotes bone marrow stem cell differentiation and proliferation by targeting miR-26a-5p in steroid-induced osteonecrosis of the femoral head

  2021cites this paper
• The role of EphB4/ephrinB2 signaling in root repair after orthodontically-induced root resorption.

  2021cites this paper
• Molecular basis of bone diseases

  2020cites this paper
• Effects of lactoferrin on bone resorption of midpalatal suture during rapid expansion in rats

  2018cites this paper
• Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway.

  2018cites this paper
• Eurycoma longifolia, a promising suppressor of RANKL-induced differentiation and activation of osteoclasts: An in vitro mechanistic evaluation

  2018cites this paper
• DIHYDROTESTOSTERONE DOWNREGULATES BONE RESORPTION ACTIVITY OF OSTEOCLASTS IN DOSE DEPENDENT MANNER: AN IN VITRO MODEL USING RAW 264.7 CELLS

  2017cites this paper
• RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis.

  2017influential citation
• Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis.

  2015cites this paper
• Wenyangbushen-induced-expression of VEGF, OPG, RANK, and RANKL in rabbits with steroid-induced femoral head avascular necrosis

  2015cites this paper
• Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis.

  2015cites this paper
• WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling

  2015cites this paper
• Tyrosine Kinase Inhibitor Tyrphostin AG490 Retards Chronic Joint Inflammation in Mice

  2014cites this paper
• myeloma cell growth resulting in strong inhibition of osteoclast formation/activity and multiple B activity κ SDX-308, a non-steroidal anti-inflammatory agent, inhibits NF-

  2013cites this paper
• Osteoprotegerin influences the bone resorption activity of osteoclasts.

  2013cites this paper
• Technetium‐99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor‐κB ligand‐induced osteoclastogenesis

  2012cites this paper
• Supplément alimentaire et substance injectable pour la prophylaxie et la thérapie de l'ostéoporose et d'autres maladies de l'os

  2012cites this paper
• Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro

  2012influential citation
• Inositol Hexakisphosphate Inhibits Osteoclastogenesis on RAW 264.7 Cells and Human Primary Osteoclasts

  2012cites this paper
• Proteoglycans and osteolysis.

  2012cites this paper
• Embryonic stem cells for osteo-degenerative diseases.

  2011cites this paper
• Protective effects of fermented rice vinegar sediment (Kurozu moromimatsu) in a diethylnitrosamine-induced hepatocellular carcinoma animal model

  2011cites this paper
• Embryonic stem cells for osteo-degenerative diseases.

  2011cites this paper
• Protective effects of fermented rice vinegar sediment (Kurozu moromimatsu) in a diethylnitrosamine-induced hepatocellular carcinoma animal model.

  2011cites this paper
• Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.

  2011cites this paper
• Embryonic Stem Cell Therapy for Osteo-Degenerative Diseases

  2011cites this paper
• OPG/RANK/RANKL AXIS IN PERIODONTOLOGY

  2010cites this paper
• Proteases and Therapeutic Approaches of Bone Tumors

  2010cites this paper
• Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesis

  2010cites this paper
• Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts

  2010cites this paper
• RANK/RANKL/OPG role in distraction osteogenesis.

  2010cites this paper
• Consecuencias clínicas de la persistencia de actividad inflamatoria en la arteritis de células gigantes. Estudio de factores implicados

  2010cites this paper
• Studies On Gender-Specific Disruption Of Bone Tissue Homeostasis By Dioxins

  2009cites this paper
• Inhibition of osteoclast formation and function by bicarbonate: Role of soluble adenylyl cyclase

  2009cites this paper
• Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro.

  2009cites this paper
• Proteases and bone remodelling.

  2009cites this paper
• Drug delivery to osteoclast receptor targets

  2009cites this paper
• Chemokines and Bone Remodeling

  2008cites this paper
• Knockouts of Se-glutathione peroxidase-1 and Cu,Zn superoxide dismutase exert different impacts on femoral mechanical performance of growing mice.

  2008cites this paper
• The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

  2008cites this paper
• Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

  2008cites this paper
• A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide.

  2008cites this paper
• High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

  2008cites this paper
• Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

  2008cites this paper
• The role of dental pulp cells in resorption of deciduous teeth.

  2008cites this paper
• The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.

  2007cites this paper
• Kurozu moromimatsu inhibits tumor growth of Lovo cells in a mouse model in vivo

  2007cites this paper
• RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

  2007cites this paper
• Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation

  2007cites this paper
• Kurozu moromimatsu inhibits tumor growth of Lovo cells in a mouse model in vivo.

  2007cites this paper
• Signal transduction and cell‐type specific regulation of matrix metalloproteinase gene expression: Can MMPs be good for you?

  2007cites this paper
• SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.

  2007cites this paper
• Differentiating primary human cells in rapid-throughput discovery applications.

  2007cites this paper
• Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite.

  2006cites this paper
• RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.

  2006cites this paper
• Osteoporosis and Vascular Calcification: Lesson from OPG KO Mice

  2005cites this paper
• JunB as a Downstream Mediator of PTHrP Actions in Cementoblasts

  2005influential citation
• Organization of transcriptional regulatory machinery in osteoclast nuclei: Compartmentalization of Runx1

  2005cites this paper
• The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.

  2004cites this paper